Home > Healthcare > Pharmaceuticals > Finished Drug Form > Acromegaly Treatment Market

Acromegaly Treatment Market Trends

Report ID: GMI9820
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Acromegaly Treatment Market Trends

Expanding R&D activities are driving the market growth by initiating a robust pipeline of innovative therapies. Pharmaceutical companies are heavily investing in the discovery and development of novel treatment options, including advanced drugs and improved delivery methods to address the burden of rare diseases including acromegaly.

For instance, in June 2024, Crinetics Pharmaceuticals, Inc. presented findings from its clinical development program for oral, once-daily investigational paltusotine in acromegaly. The data included results from the Phase 3 PATHFNDR-2 trial, a new analysis of patient-reported outcome (PRO) data from the Phase 3 PATHFNDR-1 trial, and interim long-term efficacy and safety results at 42 months from the open-label ACROBAT Advance extension study. These comprehensive results highlighted paltusotine's potential as an effective and convenient treatment option for acromegaly, reinforcing its promise in ongoing clinical development. Such trials in the pipeline are expected to spur the market growth.

Moreover, the growing focus on emerging treatment methods, strategic approaches by key players, approvals, government support and funding are further boosting market demand.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Acromegaly treatment industry size was worth USD 2.2 billion in 2023 and is projected to expand at 5.4% CAGR from 2024 to 2032, owing to the rising prevalence and incidence of acromegaly and pituitary tumors.

The pseudo acromegaly type segment in the acromegaly treatment industry is projected to record USD 1.3 billion in 2023 and is estimated to depict 5.3% CAGR between 2024 and 2032, due to its increasing diagnosis and recognition.

The medical therapy treatment segment in the acromegaly treatment industry recorded 45.7% share in 2023 due to its effectiveness and convenience of pharmacological interventions compared to surgical options.

U.S. acromegaly treatment market industry size was USD 876.4 million in 2023 and is estimated to grow at substantial CAGR between 2024 and 2032, due to its large population and high healthcare spending.